{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:33:37Z","timestamp":1761863617446,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.clcc.2016.09.010","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T11:58:19Z","timestamp":1476100699000},"page":"e171-e180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05\/06 Trials"],"prefix":"10.1016","volume":"16","author":[{"given":"Yu","family":"Sunakawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadamichi","family":"Denda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Segawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Negoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsugu","family":"Kochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-613X","authenticated-orcid":false,"given":"Masahito","family":"Kotaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Tanioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Takagane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuro","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takanori","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshifusa","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2016.09.010_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","article-title":"DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil\u2013based adjuvant therapy","volume":"103","author":"Sinicrope","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2016.09.010_bib2","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.26086","article-title":"Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer","volume":"117","author":"Tran","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.clcc.2016.09.010_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/DCR.0b013e3181c703a4","article-title":"Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival","volume":"53","author":"Benedix","year":"2010","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.clcc.2016.09.010_bib4","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1245\/s10434-008-0015-y","article-title":"Is there a difference in survival between right- versus left-sided colon cancers?","volume":"15","author":"Meguid","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib5","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2011.36.4414","article-title":"Mortality by stage for right- versus left-sided colon cancer: analysis of Surveillance, Epidemiology, and End Results\u2013Medicare data","volume":"29","author":"Weiss","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib6","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1200\/JCO.2013.48.9591","article-title":"Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy","volume":"31","author":"Sinicrope","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11605-015-3026-6","article-title":"The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis","volume":"20","author":"Yahagi","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.clcc.2016.09.010_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.10635","article-title":"Are there two sides to colorectal cancer?","volume":"101","author":"Iacopetta","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clcc.2016.09.010_bib9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-113-10-779","article-title":"Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location","volume":"113","author":"Bufill","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clcc.2016.09.010_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","article-title":"Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer","volume":"29","author":"Hutchins","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib11","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.1158\/1078-0432.CCR-11-1570","article-title":"Gene expression differences between colon and rectum tumors","volume":"17","author":"Sanz-Pamplona","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2016.09.010_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/gutjnl-2011-300865","article-title":"Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum","volume":"61","author":"Yamauchi","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2016.09.010_bib13","first-page":"755","article-title":"Distinguishing right from left colon by the pattern of gene expression","volume":"12","author":"Glebov","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clcc.2016.09.010_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gut.2003.036848","article-title":"Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid","volume":"54","author":"Birkenkamp-Demtroder","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.clcc.2016.09.010_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/tpj.2014.73","article-title":"Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy","volume":"15","author":"Maus","year":"2015","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.clcc.2016.09.010_bib16","doi-asserted-by":"crossref","first-page":"dju427","DOI":"10.1093\/jnci\/dju427","article-title":"Primary tumor location as a prognostic factor in metastatic colorectal cancer","volume":"107","author":"Loupakis","year":"2015","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.clcc.2016.09.010_bib17","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1093\/annonc\/mdt253","article-title":"Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer","volume":"24","author":"Boisen","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib18","first-page":"3600","article-title":"Gender and tumor location as predictors for efficacy: influence on endpoints in first-line treatment with FOLFIRI in combination with cetuximab or bevacizumab in the AIO KRK 0306 (FIRE3) trial","volume":"32","author":"Heinemann","year":"2014","journal-title":"ASCO Meeting Abstracts"},{"key":"10.1016\/j.clcc.2016.09.010_bib19","first-page":"3504","article-title":"Impact of primary (1{o}) tumor location on overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC): analysis of CALGB\/SWOG 80405 (Alliance)","volume":"34","author":"Venook","year":"2016","journal-title":"ASCO Meeting Abstracts"},{"key":"10.1016\/j.clcc.2016.09.010_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3109\/1354750X.2013.819038","article-title":"DUSP 4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype","volume":"18","author":"De Vriendt","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.clcc.2016.09.010_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jcb.22952","article-title":"Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux) efficacy in KRAS wild-type tumor cells","volume":"112","author":"Oliveras-Ferraros","year":"2011","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.clcc.2016.09.010_bib22","first-page":"153","article-title":"Colorectal carcinoma: pathologic aspects","volume":"3","author":"Fleming","year":"2012","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0959-8049(95)00532-3","article-title":"Survival for colon and rectal cancer in a population-based cancer registry","volume":"32A","author":"Roncucci","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2016.09.010_bib24","first-page":"686","article-title":"Changing patterns in colorectal carcinoma: a 25-year experience","volume":"58","author":"Sariego","year":"1992","journal-title":"Am Surg"},{"key":"10.1016\/j.clcc.2016.09.010_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1440-1746.2007.04923.x","article-title":"Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology","volume":"23","author":"Nawa","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clcc.2016.09.010_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00432-014-1678-3","article-title":"Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12\/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial","volume":"140","author":"Von Einem","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib27","doi-asserted-by":"crossref","first-page":"5931","DOI":"10.1200\/JCO.2009.22.4295","article-title":"KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial","volume":"27","author":"Richman","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.bjc.6605164","article-title":"Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer","volume":"101","author":"Souglakos","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2016.09.010_bib29","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S1470-2045(13)70490-X","article-title":"Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): an open-label, non-inferiority, randomised phase 3 trial","volume":"14","author":"Yamada","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2016.09.010_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.ejca.2015.03.015","article-title":"Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17","volume":"51","author":"Brule","year":"2015","journal-title":"Eur J Cancer"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816302043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002816302043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:26Z","timestamp":1761519806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002816302043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1533002816302043"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2016.09.010","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Primary Tumor Location on Clinical Outcomes of Metastatic Colorectal Cancer Treated With Cetuximab Plus Oxaliplatin-Based Chemotherapy: A Subgroup Analysis of the JACCRO CC-05\/06 Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2016.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}